- Home
- NUAI vs INBS Comparison
NUAI vs INBS Comparison
Compare NUAI & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUAI
- INBS
- Stock Information
- Founded
- NUAI N/A
- INBS 2016
- Country
- NUAI United States
- INBS United States
- Employees
- NUAI N/A
- INBS N/A
- Industry
- NUAI Oil & Gas Production
- INBS Medical Specialities
- Sector
- NUAI Energy
- INBS Health Care
- Exchange
- NUAI Nasdaq
- INBS Nasdaq
- Market Cap
- NUAI 11.3M
- INBS 11.7M
- IPO Year
- NUAI N/A
- INBS N/A
- Fundamental
- Price
- NUAI $0.47
- INBS $1.48
- Analyst Decision
- NUAI
- INBS
- Analyst Count
- NUAI 0
- INBS 0
- Target Price
- NUAI N/A
- INBS N/A
- AVG Volume (30 Days)
- NUAI 1.3M
- INBS 118.4K
- Earning Date
- NUAI 08-14-2025
- INBS 08-15-2025
- Dividend Yield
- NUAI N/A
- INBS N/A
- EPS Growth
- NUAI N/A
- INBS N/A
- EPS
- NUAI N/A
- INBS N/A
- Revenue
- NUAI $718,761.00
- INBS $3,052,532.00
- Revenue This Year
- NUAI N/A
- INBS $778.48
- Revenue Next Year
- NUAI N/A
- INBS N/A
- P/E Ratio
- NUAI N/A
- INBS N/A
- Revenue Growth
- NUAI 14.80
- INBS N/A
- 52 Week Low
- NUAI $0.38
- INBS $1.02
- 52 Week High
- NUAI $12.29
- INBS $3.00
- Technical
- Relative Strength Index (RSI)
- NUAI N/A
- INBS 43.30
- Support Level
- NUAI N/A
- INBS $1.38
- Resistance Level
- NUAI N/A
- INBS $1.54
- Average True Range (ATR)
- NUAI 0.00
- INBS 0.10
- MACD
- NUAI 0.00
- INBS 0.00
- Stochastic Oscillator
- NUAI 0.00
- INBS 38.18
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).